[go: up one dir, main page]

NO20000107L - New mixture - Google Patents

New mixture

Info

Publication number
NO20000107L
NO20000107L NO20000107A NO20000107A NO20000107L NO 20000107 L NO20000107 L NO 20000107L NO 20000107 A NO20000107 A NO 20000107A NO 20000107 A NO20000107 A NO 20000107A NO 20000107 L NO20000107 L NO 20000107L
Authority
NO
Norway
Prior art keywords
new mixture
mixture
new
blocker
pharmaceutical composition
Prior art date
Application number
NO20000107A
Other languages
Norwegian (no)
Other versions
NO20000107D0 (en
Inventor
Paul John Cummings
Ian Frederic Tulloch
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20000107D0 publication Critical patent/NO20000107D0/en
Publication of NO20000107L publication Critical patent/NO20000107L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Farmasøytisk blanding innbefattende en SSRI i hurtig frigjøringsform og en p-blokker i forsinket frigjøringsform.Pharmaceutical composition including a rapid release SSRI and a delayed release β-blocker.

NO20000107A 1997-07-11 2000-01-10 New mixture NO20000107L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714675.7A GB9714675D0 (en) 1997-07-11 1997-07-11 Novel composition
PCT/EP1998/004971 WO1999002142A2 (en) 1997-07-11 1998-07-07 Novel composition comprising an ssri and a beta-blocker

Publications (2)

Publication Number Publication Date
NO20000107D0 NO20000107D0 (en) 2000-01-10
NO20000107L true NO20000107L (en) 2000-01-10

Family

ID=10815744

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000107A NO20000107L (en) 1997-07-11 2000-01-10 New mixture

Country Status (26)

Country Link
EP (1) EP0996466A2 (en)
JP (1) JP2002508003A (en)
KR (1) KR20010021644A (en)
CN (1) CN1262627A (en)
AP (1) AP2000001728A0 (en)
AR (1) AR016128A1 (en)
AU (1) AU9340198A (en)
BG (1) BG104119A (en)
BR (1) BR9810996A (en)
CA (1) CA2295822A1 (en)
CO (1) CO4950552A1 (en)
DZ (1) DZ2556A1 (en)
EA (1) EA200000112A1 (en)
GB (1) GB9714675D0 (en)
HU (1) HUP0003074A3 (en)
ID (1) ID24191A (en)
IL (1) IL133869A0 (en)
MA (1) MA24604A1 (en)
NO (1) NO20000107L (en)
OA (1) OA11276A (en)
PE (1) PE99699A1 (en)
PL (1) PL338017A1 (en)
SK (1) SK72000A3 (en)
TR (1) TR200000074T2 (en)
WO (1) WO1999002142A2 (en)
ZA (1) ZA986138B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1121111E (en) 1998-10-15 2010-05-17 Imp Innovations Ltd Compounds for the treatment of weight loss
CA2348871C (en) 1998-11-02 2009-04-14 John G. Devane Multiparticulate modified release composition
KR100889069B1 (en) 1999-10-29 2009-03-17 유로-셀티크 소시에떼 아노뉨 Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
GB0004003D0 (en) * 2000-02-22 2000-04-12 Knoll Ag Therapeutic agents
BR0115382A (en) 2000-10-30 2003-09-16 Euro Celtique Sa Controlled release formulations of hydrocodone, method of producing effective analgesia, process of preparing a pharmaceutical form of a controlled release oral solid, controlled release of the oral dosage form and use of the pharmaceutical form
WO2006030306A2 (en) * 2004-09-17 2006-03-23 Neurocure Ltd Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder
CN100469356C (en) * 2006-09-08 2009-03-18 山东益康药业有限公司 Slowly released tablet of compound atenolol, and preparation method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732335C2 (en) * 1976-07-27 1983-01-20 Sandoz-Patent-GmbH, 7850 Lörrach Tablet for the enteral administration of indolyloxyalkanolamine derivatives
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of a drug by a serotonin 1A receptor antagonist
DE69607904T2 (en) * 1995-08-16 2000-10-05 Eli Lilly And Co., Indianapolis Potentiation of serotonin drug response
EP0792649A1 (en) * 1996-02-29 1997-09-03 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
MA24604A1 (en) 1999-04-01
EA200000112A1 (en) 2000-10-30
GB9714675D0 (en) 1997-09-17
CO4950552A1 (en) 2000-09-01
ID24191A (en) 2000-07-13
OA11276A (en) 2003-07-31
HUP0003074A2 (en) 2001-01-29
HUP0003074A3 (en) 2001-12-28
PL338017A1 (en) 2000-09-25
BG104119A (en) 2000-12-29
TR200000074T2 (en) 2000-05-22
AR016128A1 (en) 2001-06-20
IL133869A0 (en) 2001-04-30
KR20010021644A (en) 2001-03-15
JP2002508003A (en) 2002-03-12
DZ2556A1 (en) 2003-02-15
SK72000A3 (en) 2000-12-11
PE99699A1 (en) 1999-12-21
CN1262627A (en) 2000-08-09
BR9810996A (en) 2000-08-08
WO1999002142A2 (en) 1999-01-21
EP0996466A2 (en) 2000-05-03
CA2295822A1 (en) 1999-01-21
AU9340198A (en) 1999-02-08
NO20000107D0 (en) 2000-01-10
WO1999002142A3 (en) 1999-04-15
AP2000001728A0 (en) 2000-03-31
ZA986138B (en) 2000-01-10

Similar Documents

Publication Publication Date Title
DE60010098D1 (en) 28-EPIRAPALOGE
DE69837140D1 (en) ALGINATGELE WITH DELAYED RELEASE
AR004357A1 (en) 1-PHENYL-2-DIMETHYLAMINOMETHYL-CYCLOHEXAN-1-OL COMPOUNDS, AND PREPARATION PROCEDURE FOR SUCH COMPOUNDS.
HUP0101155A3 (en) Imidazonaphthyridines, pharmaceutical compositions thereof and intermediates
NO20002470L (en) New material composition
DE59709549D1 (en) premix
NO994003L (en) Pharmaceutical mixture
YU58599A (en) Sustained-release delayed gels
IT1287174B1 (en) PHARMACOLOGICALLY ACTIVE DIARYL-CYCLOMETHYLENPYRAZOLES, PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
NO20000107L (en) New mixture
FI972988L (en) Methods and pharmaceutical compositions using desmethylselegiline
PT929299E (en) 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINS AND 2-AMINOCYCLOHEPTA ¬B | BENZOFURANOS SUBSTITUIDOS
BG100248A (en) SQUALENSENTEZA INHIBITORS
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
BR0112600A (en) Calcally Compounds
AP2002002547A0 (en) Calcilytic compounds.
ID17640A (en) COMPOSITION OF PESTICIDES
EP1383511A4 (en) Calcilytic compounds
NO985079L (en) Explosive formulation
FR2747686B1 (en) FLUORESCENT MATERIAL
FI961364L (en) Drug composition
NO960796D0 (en) Benzothiophenone Compounds, Intermediates, Compositions and Methods
JO2087B1 (en) Pharmaceutical formulations
BR9701895B1 (en) estrogenic agents and pharmaceutical composition comprising them.
IT237549Y1 (en) CLAMP FOR JOINERY, JEWELERY AND SIMILAR

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application